Literature DB >> 29056155

Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.

Marisa Roberto1, Samantha R Spierling2, Dean Kirson2, Eric P Zorrilla2.   

Abstract

Drug addiction is a complex disorder that is characterized by compulsivity to seek and take the drug, loss of control in limiting intake of the drug, and emergence of a withdrawal syndrome in the absence of the drug. The transition from casual drug use to dependence is mediated by changes in reward and brain stress functions and has been linked to a shift from positive reinforcement to negative reinforcement. The recruitment of brain stress systems mediates the negative emotional state produced by dependence that drives drug seeking through negative reinforcement mechanisms, defined as the "dark side" of addiction. In this chapter we focus on behavioral and cellular neuropharmacological studies that have implicated brain stress systems (i.e., corticotropin-releasing factor [CRF]) in the transition to addiction and the predominant brain regions involved. We also discuss the implication of CRF recruitment in compulsive eating disorders.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol dependence; CRF; Extended amygdala; GABA

Mesh:

Substances:

Year:  2017        PMID: 29056155      PMCID: PMC6155477          DOI: 10.1016/bs.irn.2017.06.004

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  293 in total

Review 1.  CRH-BP: the regulation and function of a phylogenetically conserved binding protein.

Authors:  Nicole J Westphal; Audrey F Seasholtz
Journal:  Front Biosci       Date:  2006-05-01

2.  Beta-2 adrenergic receptors mediate stress-evoked reinstatement of cocaine-induced conditioned place preference and increases in CRF mRNA in the bed nucleus of the stria terminalis in mice.

Authors:  Jayme R McReynolds; Oliver Vranjkovic; Malia Thao; David A Baker; Khadijah Makky; Yiwei Lim; John R Mantsch
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

3.  Distribution of GABA immunoreactivity in the amygdaloid complex of the cat.

Authors:  D Paré; Y Smith
Journal:  Neuroscience       Date:  1993-12       Impact factor: 3.590

4.  Role of corticotropin-releasing factor in the median raphe nucleus in yohimbine-induced reinstatement of alcohol seeking in rats.

Authors:  A D Lê; Douglas Funk; Kathleen Coen; Zhaoxia Li; Yavin Shaham
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

5.  Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.

Authors:  Leandro F Vendruscolo; David Estey; Vivian Goodell; Lauren G Macshane; Marian L Logrip; Joel E Schlosburg; M Adrienne McGinn; Eva R Zamora-Martinez; Joseph K Belanoff; Hazel J Hunt; Pietro P Sanna; Olivier George; George F Koob; Scott Edwards; Barbara J Mason
Journal:  J Clin Invest       Date:  2015-06-29       Impact factor: 14.808

6.  Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.

Authors:  Sonia Tucci; Survjit Cheeta; Pallab Seth; Sandra E File
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

7.  Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats.

Authors:  Adrie W Bruijnzeel; Elysia Small; Tim M Pasek; Hidetaka Yamada
Journal:  Behav Brain Res       Date:  2010-03-01       Impact factor: 3.332

8.  Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice.

Authors:  Simranjit Kaur; Ju Li; Mary P Stenzel-Poore; Andrey E Ryabinin
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

9.  Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Authors:  Marisa Roberto; Maureen T Cruz; Nicholas W Gilpin; Valentina Sabino; Paul Schweitzer; Michal Bajo; Pietro Cottone; Samuel G Madamba; David G Stouffer; Eric P Zorrilla; George F Koob; George R Siggins; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2010-01-08       Impact factor: 13.382

10.  A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice.

Authors:  M Foster Olive; Kristin K Mehmert; Heather N Koenig; Rosana Camarini; Joseph A Kim; Michelle A Nannini; Christine J Ou; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2002-10-24       Impact factor: 4.530

View more
  17 in total

1.  Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Bruce Ladenheim; Michael T McCoy; Christie Brannock; Jennifer Schroeder; Jean Lud Cadet
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

Review 2.  Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.

Authors:  Angela E Snyder; Yuval Silberman
Journal:  Neuropharmacology       Date:  2021-10-06       Impact factor: 5.250

3.  Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies.

Authors:  Mehdi Farokhnia; Christopher T Rentsch; Vicky Chuong; M Adrienne McGinn; Sophie K Elvig; Eliza A Douglass; Luis A Gonzalez; Jenna E Sanfilippo; Renata C N Marchette; Brendan J Tunstall; David A Fiellin; George F Koob; Amy C Justice; Lorenzo Leggio; Leandro F Vendruscolo
Journal:  Mol Psychiatry       Date:  2022-09-20       Impact factor: 13.437

4.  Ethanol withdrawal-induced adaptations in prefrontal corticotropin releasing factor receptor 1-expressing neurons regulate anxiety and conditioned rewarding effects of ethanol.

Authors:  Reesha R Patel; Sarah A Wolfe; Vittoria Borgonetti; Pauravi J Gandhi; Larry Rodriguez; Angela E Snyder; Shannon D'Ambrosio; Michal Bajo; Alain Domissy; Steven Head; Candice Contet; R Dayne Mayfield; Amanda J Roberts; Marisa Roberto
Journal:  Mol Psychiatry       Date:  2022-06-06       Impact factor: 13.437

Review 5.  A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

Authors:  A Leslie Morrow; Giorgia Boero; Patrizia Porcu
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

Review 6.  The Role of the Central Amygdala in Alcohol Dependence.

Authors:  Marisa Roberto; Dean Kirson; Sophia Khom
Journal:  Cold Spring Harb Perspect Med       Date:  2021-02-01       Impact factor: 6.915

Review 7.  The Neuroscience of Drug Reward and Addiction.

Authors:  Nora D Volkow; Michael Michaelides; Ruben Baler
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

8.  Insights into the Neurobiology of Craving in Opioid Use Disorder.

Authors:  Lindsay M Lueptow; Elizabeth C Shashkova; Margaret G Miller; Christopher J Evans; Catherine M Cahill
Journal:  Curr Anesthesiol Rep       Date:  2020-09-29

Review 9.  Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.

Authors:  Michael T Bardo; Lindsey R Hammerslag; Samantha G Malone
Journal:  Neuropharmacology       Date:  2021-04-13       Impact factor: 5.273

Review 10.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.